On behalf of all the people who suffer from a chronic disease and desperately need a cure, we would like thank the individuals and organizations who support and sponsor us.
Join our supporters
Call us to make a donation at 585-200-5546
We are now collecting funds to hire a writer to translate Dr. Polansky's highly technical "purple" book into a book suitable for the general public. We believe that everyone should be familiar with Dr. Polansky's great discovery, not only professional scientists. If you donate more than $500, we will send you a signed copy of Dr. Polansky's "purple" book.
If you want a cure for cancer, heart disease, or diabetes, you need to donate to the CBCD. Don't count on the National Institute of Health (NIH), or the biotech/pharmaceutical industry to do the job. With all the money they spent on this problem, they have very little to show for it.
In 1971, during the State of the Union address, President Nixon declared the war on cancer proposing "an intensive campaign to find a cure for cancer." Since 1971, Americans spent, through taxes, donations, and private R&D, about $200 billion in inflation-adjusted dollars. This money produced 1.56 million papers on cancer. Yet, today we are no closer to a cure than we were in 1971. Why?
Consider what Dr. Almog says in his paper: Drug Industry in "depression"1: "When the basic science/biology of disease is not available, no new drugs come to market." With the billion of dollars spent by the NIH on basic science, and the millions of papers published on the topic, the question is, "Why isn’t the basic science/biology of disease available? Individual discoveries in the biology of human disease are cornerstone in new treatments. However, in drug discovery, these basic science/biology discoveries are seemingly unrelated dots. To connect the dots you need a theory. The Blind Men and the Elephant is a famous story about six blind men encountering an elephant for the first time. Each man, seizing on the single feature of the animal, which he appeared to have touched first, and being incapable of seeing it whole, loudly maintained his limited opinion on the nature of the beast. The elephant was considered a wall, a spear, a snake, a tree, a fan or a rope, depending on whether the blind men had first grasped the creature’s side, tusk, trunk, knee, ear or tail. The story epitomizes the problem of the reductionist approach in biology. A recent book Microcompetition with Foreign DNA and the Origin of Chronic Disease, by Hanan Polansky , presents an alternative. The book identifies the disruption that causes atherosclerosis, cancer, obesity, osteoarthritis, type II diabetes, alopecia, type I diabetes, multiple sclerosis, asthma, lupus, thyroiditis, inflammatory bowel disease, rheumatoid arthritis, psoriasis, atopic dermatitis, graft versus host disease, and other chronic diseases, and describes the sequence of events that leads from the disruption to the molecular, cellular, and clinical effects."
On the one hand, the expenditure on research is increasing. On the other, the number of new drugs is decreasing. The professionals call this situation the productivity crisis in drug discovery.
You can also make a donation by sending a check or money order, payable to The CBCD, to our address: The CBCD, 2030 Elmwood Ave., Rochester, NY 14620.
As a 501c3 organization, all donations to the CBCD are tax deductible.
Spread the word
Tell your friends and colleagues about our center, its mission, and discoveries. Link our website to your website. We have good news. Share the news with others.
1. Almog, D. Drug industry in "Depression". Med Sci Monit. 2005 Jan;11(1):SR1-4.
(We strongly recommend this paper. It's presents a unique description of the relationship between academic research and commercial drug discovery.)
2. Taylor D. Fewer New Drugs from the Pharmaceutical Industry. BMJ. 2003 Feb 22;326(7386):408-9.
© 2010 CBCD. All rights reserved.